SCHEMBL9986177

SCHEMBL9986177

Clc1ncccc1-c1nc2ccccc2[nH]1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 11/20 0.68
RAB9A P51151 10/20 0.68
MEN1 O00255 1/20 0.68
KMT2A Q03164 1/20 0.68
CDK1 P06493 1/20 0.68
CDK2 P24941 1/20 0.68
MKNK1 Q9BUB5 1/20 0.68
MKNK2 Q9HBH9 1/20 0.68
KDM4E B2RXH2 10/20 0.66
ALDH1A1 P00352 10/20 0.66
GPR55 Q9Y2T6 1/20 0.66
NPSR1 Q6W5P4 5/20 0.62
SMN1; SMN2 Q16637 5/20 0.58
HPGD P15428 5/20 0.57
PKM P14618 3/20 0.57
HSD17B10 Q99714 3/20 0.57
GAA P10253 2/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
LMNA P02545 1/20 0.57
MTOR P42345 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6530312 0.82 CDK1 (0.69) NPC1RAB9ACDK1CDK2MKNK1
SCHEMBL19960361 0.82 NPC1 (0.72) NPC1RAB9AMEN1KMT2ACDK1
SCHEMBL18891696 0.82 NPC1 (0.68) NPC1RAB9AMEN1KMT2ACDK1
SCHEMBL3090064 0.81 NPC1 (1.00) NPC1RAB9AMEN1KMT2ACDK1
SCHEMBL222463 0.81 CDK1 (1.00) NPC1RAB9ACDK1CDK2MKNK1
SCHEMBL28036109 0.81 CDK1 (0.68) NPC1RAB9ACDK1CDK2MKNK1
SCHEMBL30874471 0.81 CDK1 (1.00) NPC1RAB9ACDK1CDK2MKNK1
SCHEMBL227743 0.80 NPC1 (0.78) NPC1RAB9ACDK1CDK2MKNK1
SCHEMBL162191 0.80 NPC1 (1.00) NPC1RAB9ACDK1CDK2MKNK1
SCHEMBL29695905 0.80 NPC1 (1.00) NPC1RAB9ACDK1CDK2MKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9273080-B2 Metal complexes MEREK PATENT GMBH (DE) 2016-03-01 US disclosed
US-20130082209-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-04-04 US disclosed
WO-2011157339-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2011-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130082209-A1 METAL COMPLEXES MCOLN2, MCOLN1, AP1M1 NPC1 1682/4885RAB9A 1404/4885MEN1 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.